期刊文献+

血管紧张素Ⅱ受体Ⅰ阻滞剂抑制血管平滑肌细胞增殖、迁移的实验研究 被引量:5

Inhibitory effects of angiotensin type 1 receptors antagonist on vascular smooth muscle cells proliferation and migration in rabbit carotid injury model
下载PDF
导出
摘要 目的:观察血管紧张素Ⅱ受体Ⅰ阻滞剂Valsartan对家兔颈动脉球囊损伤模型动脉中膜血管平滑肌细胞增殖、迁移的抑制作用。方法:健康家兔制作颈动脉球囊损伤模型,随机分为对照组(n=10)和Valsartan治疗组(n=10),治疗组术后予Valsartan喂食,10mg/(kg·d),共10天,对照组正常喂食。各组动物术前和术后3天、1、2、4、8周留取静脉血,放免法检测内皮素(ET-I);术后4、8周每组随即处死动物5只,HE染色、原位标记凋亡细胞(TUNEL)和增殖细胞核抗原(PCNA)免疫组化染色,应用光学显微镜和计算机图像分析系统对切片进行图像分析。结果:术后3天、1、2、4、8周治疗组血浆ET-1水平低于对照组(P<0.01);术后4周和8周治疗组血管壁平滑肌细胞凋亡率高于对照组,PCNA阳性率低于对照组(P<0.05);动脉内膜、中膜厚度和面积小于对照组(P<0.01);残余管腔面积大于对照组(P<0.01)。结论:血管紧张素Ⅱ受体Ⅰ阻滞剂Valsartan可以抑制内膜受损动脉中膜平滑肌细胞增殖和向内膜迁移,并促进其凋亡,预防受损动脉内膜过度增生,管腔狭窄。 Objective: To investigate the effects of Angiotensin type 1 receptors antagonist (Valsartan) on the proliferation and migration of vascular smooth muscle cells and neointimal thickening in rabbit carotid injury model. Methods: Twenty rabbits undergoing ballon-induced injuries in right common carotids were randomly divided into control group (n = 10)and Valsartan-treated group (n = 10).Rabbits in the late group were administrated with Valsartan 10 mg/(kg·d) plus normal food and water for 10 days. Changes of the levels of plasma endothelin-1 (ET-1 )were measured by radioimmunoassay before operation and 3 days, 1,2,4,8 weeks after operation respectively. Four weeks and 8 weeks after operation ,5 rabbits of each group were killed and the segments of balloninjuried carotids were harvested for pathomorphological examination. The vessels were processed to examine VSMCs proliferation by hematoxylin-eosin staining, proliferation cell nuclear antigen (PCNA)immunohistochemistry staining and apoptotic body staining by terminal deocynucleotidyl transferase mediated dUPT nick-end labeling (TUNEL). Results: The plasma levels of ET-I increased after injury. Valsartan lowed them significantly (P 〈 0.01 ).Compared with the control group, VSMCs proliferation in medial was significantly inhibited and VSMCs apoptoese was significantly increased in.Valsartan-treated group (P〈 0.01).Neointimal thickening was observed in all ballon-injuied vessels. Valsartan significantly reduced the neointimal thickening and increased the lumen area (P 〈 0.01). Conclusion: Angiotensin type 1 receptors antagonist has remarkable inhibiting effects on VSMCs proliferation and migration, resulting in attenuating neointimal thickening in rabbit carotid injury model.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2006年第2期113-117,F0004,共6页 Journal of Nanjing Medical University(Natural Sciences)
关键词 血管紧张素Ⅱ受体Ⅰ阻滞剂 血管平滑肌细胞 颈动脉球囊损伤 内皮素 再狭窄 angiotensin type 1 receptors antagonist rabbit carotid injury model neointimal VSMCs ET-1
  • 相关文献

参考文献22

  • 1Hoffmann R,Jansen C,Konig A,et al.Stent design related neointimal tissue proliferation in human coronary arteries:an intravascular ultrasound study[J].Eur Heart J,2001,22:2007-2014.
  • 2Kastrati A,Mehilli J,Dirschinger J,et al.Restenosis after coronary placement of various stent types[J].Am J Cardiol,2001,87:34-39.
  • 3Weiss D,Kools JJ,Taylor WR.Angiotensin Ⅱ-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice[J].Circulation,2001,103:448-454.
  • 4Urata H,Healy B,Stewart RW,et al.Angiotensin Ⅱ-forming pathways in normal and failing hearts[J].Circ Res,1990,66:883-890.
  • 5Urata H,Kinoshita A,Misono KS,et al.Identification of a highly specific chymase as the major angiotensin Ⅱ-forming enzyme in the human heart[J].J Biol Chem,1990,265:22348-22357.
  • 6Touyz RM,Schiffrin EL.Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin Ⅱ in vascular smooth muscle cells[J].Pharmacol Rev,2000,52:639-672.
  • 7Petrie MC,Padmanabhan N,McDonald JE,et al.Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin Ⅱ generation in resistance arteries from patients with heart failure and coronary heart disease[J].J Am Coll Cardiol,2001,37:1056-1061.
  • 8Scott N,Wilcox J.The role of adventitial vasculature in restenosis:a new view of an old problem[J].J Am Coll Cardiol,1998,32:2080-2087.
  • 9Drechsel S,Bertel O,Lafont A.Michanisms and prevention of restenosis after coronary angioplasty[J].Sxhweiz Med Wochenschr,1998,128:497-504.
  • 10Schwartz SM,deBlois D,O'Brien ER.The intima.Soil for atherosclerosis and restenosis[J].Circ Res,1995,77:445-465.

同被引文献51

  • 1孙成林,段志泉,辛世杰,冯宗承,张京红,张令宇,张强.血管紧张素Ⅱ1型受体短发夹环RNA对大鼠血管平滑肌细胞增殖的影响[J].中国应用生理学杂志,2004,20(3):263-267. 被引量:6
  • 2刘勃,胡大一,唐朝枢,汪丽蕙.内皮素抗血清对大鼠主动脉球囊损伤后内膜增生的影响[J].中华心血管病杂志,1995,23(6):460-462. 被引量:15
  • 3马丽,刘苏健,邓勇志,马捷,孙宗全,胡志伟.靶向Pik3cb RNA干扰对大鼠血管平滑肌细胞增殖的影响[J].中华普通外科杂志,2007,22(5):378-381. 被引量:3
  • 4刘苏健,马丽,邓勇志,孙宗全,陈家军,苏刚.靶向Pik3cb shRNA表达载体的构建及其对大鼠血管平滑肌细胞凋亡的影响[J].中华实验外科杂志,2007,24(6):712-714. 被引量:2
  • 5Hojo Y, Ikeda U, Katsuki T, et al. Matrix metalloproteinase expression in the coronary circulation induced by coronary angioplasty[J]. Atherosclerosis, 2002, 161 (1): 185-192.
  • 6Greemers E E, Cleutjens J P, Smits J M, et al. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? [J]. Circ Res, 2001, 89(3):201-210.
  • 7Soinale F G, Coker M L, Bond B R, et al. Myocardial matrix degradation and matelloproteinase acdvation in the failing heart: a potential therapeutic target[J]. Cardiovase Res, 2000, 46(2):225-238.
  • 8Boyle J R, McDermott E, Crowther M, et al. Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease[J]. J Vasc Surg, 1998, 27(2):354-361.
  • 9Schwartz Z, Lohmarm C H, Wieland M, et al. Osteoblast proliferation and differentiation on dentin slices are modulat- ed by pretreatment of the surface with tetracycline or osteo- clasts [J], J Periodontol, 2000, 71(4):586-597.
  • 10Greenwald R A, Golub L M, Ramamurthy N S, et al. In vitro sensitivity of the three mammalian collagtenases to tetracyclines inhibition: relationship to bone and cartilage degrada- tion[J]. Bone, 1998, 22(1):33-38.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部